Christopher Twitty
Director, ZyVersa Therapeutics, Inc.
Companies
- Skye Bioscience, Inc.Chief Scientific Officer Apr 25, 2025 to now1
- ZyVersa Therapeutics, Inc.Board member Dec 20, 2021 to Mar 10, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Skye Bioscience, Inc. SKYE81,242 shares3$129.2K at $1.59Apr 25, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3